What happened to Aphria shares?
Jun 03, 2021 · Aphria has stopped trading and all Aphria shares are now converted to Tilray shares. Article continues below advertisement The merger had got delayed due to the delay in approval from Tilray ...
What happens to Tilray stock when Aphria buys out Tilray?
Apr 03, 2022 · Aphria's stock was trading at C$3.68 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, APHA stock has increased by 349.7% and is now trading at C$16.55. View …
Should you hold Aphria (APHA) stock?
May 20, 2021 · Real-time trade and investing ideas on Aphria Inc. APHA from the largest community of traders and investors. Rooms Shows Rankings Earnings Newsletters Shop. Cancel. Log In. Sign Up. DOW 0.00%. S&P 500 0.00%. NASDAQ 0.00%. Trending now. Aphria Inc. 15.38 0.07 (0.45%) Watch. Aphria Inc. NYSE Updated May 20, 2021 4:00 AM.
When will TLRY shareholders vote on the merger with Aphria?
May 03, 2021 · In an all-stock deal agreed to last December, each Aphria share held as of April 30 was swapped for 0.8381 of a Tilray share. Aphria's CEO Irwin Simon is …
What happens when Aphria and Tilray merger?
Under the deal, structured as a reverse acquisition of Tilray, each Aphria shareholder will receive 0.8381 Tilray shares for each Aphria share held. That means Aphria shareholders would own roughly 62% of outstanding Tilray shares.May 3, 2021
Will Aphria stock become Tilray?
NEW YORK & LEAMINGTON, Ontario--(BUSINESS WIRE)--May 3, 2021-- Tilray, Inc. (“Tilray”) and Aphria Inc. (“Aphria”) today announced the completion of the previously announced business combination, ushering in a new era in the global cannabis industry.
Should I sell Aphria stock?
Stockchase rating for Aphria Inc is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.
Is Aphria a good stock to buy now?
Currently, Aphria is trading at close to 0.73 times Tilray's share price. The single most compelling reason to buy Aphria stock right now is that this ratio absolutely must increase to the 0.8381 ratio included in the merger agreement.Mar 11, 2021
Is Sundial growers a buy?
The price has been going up and down for this period, and there has been a -18.65% loss for the last 2 weeks....Predicted Opening Price for Sundial Growers Inc. of Thursday, April 21, 2022.Fair opening price April 21, 2022Current price$0.53$0.53 (Undervalued)
What happens to APHA shares after merger?
After Aphria and Tilray merge, the combined entity will be called Tilray and the shares will continue to trade on Nasdaq under the ticker TLRY. Yet the terms of the deal look more advantageous to Aphria. First of all, the company's CEO and chairman, Irwin Simon, will remain at the helm.Mar 22, 2021
Is Aphria stock delisted?
Rivals Canopy Growth Corp and Aphria Inc also moved their U.S. listings to the Nasdaq in 2020, citing lower costs. Aphria delisted this year after its reverse merger with Nasdaq-listed Tilray . Aurora's shares will start trading on the Nasdaq on May 25 under the ticker symbol “ACB.”May 13, 2021
Should I hold Aphria?
The consensus among Wall Street analysts is that investors should "hold" Aphria stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in APHA, but not buy additional shares or sell existing shares.
What is Aphria stock worth?
Key Turning Points52-Week High32.29Fibonacci 50%17.53Last Price15.38Fibonacci 38.2%14.0552-Week Low2.781 more row•Apr 30, 2021
Is Aphria a buy right now?
4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aphria in the last twelve months. There are currently 3 hold ratings and 1...
What price target have analysts set for APHA?
4 analysts have issued 1-year price objectives for Aphria's shares. Their forecasts range from C$16.00 to C$28.00. On average, they anticipate Aphr...
Who are Aphria's key executives?
Aphria's management team includes the following people: Mr. Irwin D. Simon , CEO & Chairman (Age 62, Pay $6.54M) Mr. Carl A. Merton , Chief Fin...
Who are some of Aphria's key competitors?
Some companies that are related to Aphria include Bausch Health Companies (BHC) , Valeant Pharmaceuticals International (VRX) , Evotec (EVT) ,...
What other stocks do shareholders of Aphria own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Aphria investors own include Aurora Cannabis (ACB) , Cano...
What is Aphria's stock symbol?
Aphria trades on the Toronto Stock Exchange (TSX) under the ticker symbol "APHA."
How do I buy shares of Aphria?
Shares of APHA and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadia...
How much money does Aphria make?
Aphria has a market capitalization of C$0.00 and generates C$611.06 million in revenue each year.
How many employees does Aphria have?
Aphria employs 1,200 workers across the globe.
Is Aphria a buy right now?
6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aphria in the last twelve months. There are currently 5 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" Aphria stock.
What stocks does MarketBeat like better than Aphria?
Wall Street analysts have given Aphria a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Aphria wasn't one of them.
What price target have analysts set for APHA?
6 Wall Street analysts have issued twelve-month target prices for Aphria's shares. Their forecasts range from C$10.75 to C$28.00. On average, they anticipate Aphria's stock price to reach C$18.34 in the next twelve months.#N#View analysts' price targets for Aphria or view top-rated stocks among Wall Street analysts.
Who are some of Aphria's key competitors?
Some companies that are related to Aphria include Bausch Health Companies (BHC), Valeant Pharmaceuticals International (VRX), Canopy Growth (WEED), Evotec (EVT), Hikma Pharmaceuticals (HIK), Aurora Cannabis (ACB), OrganiGram (OGI), The Hydropothecary (THCX), HEXO (HEXO), Knight Therapeutics (GUD), HLS Therapeutics (HLS), Benchmark (BMK), Amryt Pharma (AMYT), The Supreme Cannabis (FIRE) and ESSA Pharma (EPI).#N#View all of APHA's competitors..
What other stocks do shareholders of Aphria own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Aphria investors own include Aurora Cannabis (ACB), Canopy Growth (WEED), (CGC), Aurora Cannabis (ACB), OrganiGram (OGI), KushCo (KSHB), NVIDIA (NVDA), CannTrust (CTST), Cronos Group (CRON) and Cronos Group (CRON).
What is Aphria's stock symbol?
Aphria trades on the Toronto Stock Exchange (TSX) under the ticker symbol "APHA."
How do I buy shares of Aphria?
Shares of APHA and other Canadian stocks can be purchased through an online brokerage account.
When will tilray and aphria merge?
Tilray (NASDAQ: TLRY) shareholders will vote on the all-stock merger with Aphria (NASDAQ: APHA ) on April 30. Aphria shareholders will receive 0.8381 shares of TLRY stock for every one share of APHA stock they own. Aphria’s shareholders have already voted and approved the merger on April 15.
How much did Tilray lose in 2020?
Tilray lost 271 million CAD for the year ending Dec. 2020 and Aphria has lost 361 million CAD in the nine month period ending Feb. 28. That equals 632 million in losses (U.S. $505 million). Hopefully, the merger will find more than 100 million CAD in synergies to make this company profitable.
Is Aphria a cash company?
Aphria has a strong balance sheet and cash position. The $5.21 billion cannabis company reported $543.3 million in net revenues for fiscal 2020, a 129% growth versus fiscal 2019. As of June 8, 2020, the stock is trading at the NASDAQ after transferring from the New York Stock Exchange.
Will Aphria grow in the US?
According to Tamy Chen, a market analyst at BMO Capital Markets, the legal changes would allow Canadian growers to enter the U.S. marijuana market. Aphria is well positioned to continue generating strong sales growth in 2021 due to the recent developments.
Is Aphria legal in Canada?
Aphria is still in the early stages of its life cycle as a competitor in Canada's legal cannabis market and in the international medical cannabis business. The company's Q2 results only included a couple of weeks of adult-use recreational sales in Canada; Q3 was the first full quarter of unrestricted sales in this important market.
Is a single quarter failure to hit analysts' estimates a worry?
Typically, a single quarter's failure to hit analysts' estimates isn't anything for investors to worry about. That's especially true when the reasons for the miss were temporary in nature. And that's the case for Aphria with its Q3 performance.